Skip to main content

Closed

ODTX: Odyssey Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-5415.2%

ROIC-64.4%

Financially safe

Stretched

Debt / equity-0.06×

Interest coverage-9479.8×

Current ratio7.20×

Odyssey Therapeutics, Inc.

ODTXNASDAQ Global Market·USD·Closed

Odyssey Therapeutics, Inc.

ODTXNASDAQ·USD·Closed

$18.93

+2.77%

$18.93

+$0.51 (2.77%)

52W Range

74thpctl

Volume

0.46×avg

Mkt Cap

572.23MUSD

P/E

-3.5TTM

Div Yield

–ann

52W Range

74thpctl

Volume

0.46×avg

Market Cap

572.23MUSD

P/E Ratio

-3.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings